Juvenescence US Corp.

Insider Reports History

Entity
Company
Location
303 A College Road East, Princeton, NJ
Signature
/s/ David Gill, Vice President and Treasurer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Juvenescence US Corp.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AgeX Therapeutics, Inc. Director, 10%+ Owner Common Stock 16.4M $9.7M $0.59 Mar 14, 2023 Direct

Insider Reports Filed by Juvenescence US Corp.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGE AgeX Therapeutics, Inc. Mar 14, 2023 0 $0 3 Mar 22, 2023 Director, 10%+ Owner